The potential use of the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a component of personalized medicine in selective cancers.

Dupouy, Sandra; Mourra, Najat; Doan, Van Kien; Gompel, Anne; Alifano, Marco; Forgez, Patricia

Dupouy, Sandra; Mourra, Najat; Doan, Van Kien; Gompel, Anne; Alifano, Marco; Forgez, Patricia.

Affiliation

Dupouy S; INSERM-UPMC UMR_S938, Hôpital Saint-Antoine, 184 rue du Faubourg Saint-Antoine, 75012 Paris, France.

Biochimie ; 93(9): 1369-78, 2011 Sep.

Article in En | MEDLINE | ID: mdl-21605619

Subject(s)

Neoplasms/metabolism; Neurotensin/metabolism; Receptors, Neurotensin/metabolism; Animals; Cell Movement; Disease Progression; Humans; Neoplasms/genetics; Neoplasms/pathology; Neurotensin/genetics; Precision Medicine; Signal Transduction

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neurotensin / Receptors, Neurotensin / Neoplasms Limits: Animals / Humans Language: En Journal: Biochimie Year: 2011 Document type: Article Affiliation country: France Country of publication: France

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google